D
David A. Gerber
Researcher at University of North Carolina at Chapel Hill
Publications - 154
Citations - 4540
David A. Gerber is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 33, co-authored 137 publications receiving 4065 citations. Previous affiliations of David A. Gerber include University of Cincinnati & Kaleida Health.
Papers
More filters
Journal ArticleDOI
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK)
TL;DR: The consensus was that Regional Review Boards (RRB) should determine listing for SLK, as with other MELD exceptions, with automatic approval for: End‐stage renal disease with cirrhosis and symptomatic portal hypertension or hepatic vein wedge pressure gradient ≥ 10 mm Hg.
Journal ArticleDOI
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets
Vincenzo Cardinale,Yunfang Wang,Guido Carpino,Cai Bin Cui,M. Gatto,Massimo Rossi,Pasquale Berloco,Alfredo Cantafora,Eliane Wauthier,Mark E. Furth,Luca Inverardi,Juan Domínguez-Bendala,Camillo Ricordi,David A. Gerber,Eugenio Gaudio,Domenico Alvaro,Lola M. Reid,Lola M. Reid +17 more
TL;DR: The phenotypes and availability from all age donors suggest that these stem/progenitors have considerable potential for regenerative therapies of liver, bile duct, and pancreatic diseases including diabetes.
Journal ArticleDOI
Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors
Babak J. Orandi,Xun Luo,Allan B. Massie,J. M. Garonzik-Wang,Bonnie E. Lonze,Rizwan Ahmed,K. J. Van Arendonk,Mark D. Stegall,Stanley C. Jordan,Jose Oberholzer,Ty B. Dunn,Lloyd E. Ratner,Sandip Kapur,Ronald P. Pelletier,John P. Roberts,Marc L. Melcher,Pooja Singh,Debra L. Sudan,Marc P. Posner,Jose M. El-Amm,Ron Shapiro,Matthew Cooper,George S. Lipkowitz,Michael A. Rees,Christopher L. Marsh,Bashir R. Sankari,David A. Gerber,P. W. Nelson,J. Wellen,Adel Bozorgzadeh,A O Gaber,A O Gaber,Robert A. Montgomery,Dorry L. Segev +33 more
TL;DR: This multicenter study validated single-center evidence that patients who received kidney transplants from HLA-incompatible live donors had a substantial survival benefit as compared with patients who did not undergo transplantation and those who waited for transplant from deceased donors.
Journal ArticleDOI
Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds.
Yunfang Wang,Cai Bin Cui,Mitsuo Yamauchi,Patricia A. Miguez,Marsha Lynn Roach,Richard Harold Malavarca,M. Joseph Costello,Vincenzo Cardinale,Vincenzo Cardinale,Eliane Wauthier,Claire Barbier,David A. Gerber,Domenico Alvaro,Lola M. Reid +13 more
TL;DR: Biomatrix scaffolds can be used for biological and pharmaceutical studies of lineage‐restricted stem cells, for maintenance of mature cells, and, in the future, for implantable, vascularized engineered tissues or organs.
Journal ArticleDOI
Quantifying the risk of incompatible kidney transplantation: a multicenter study.
Babak J. Orandi,Jacqueline Garonzik-Wang,Allan B. Massie,Andrea A. Zachary,J. R. Montgomery,K. J. Van Arendonk,Mark D. Stegall,Stanley C. Jordan,Jose Oberholzer,Ty B. Dunn,Lloyd E. Ratner,Sandip Kapur,Ronald P. Pelletier,John P. Roberts,Marc L. Melcher,Pooja Singh,Debra L. Sudan,Marc P. Posner,Jose M. El-Amm,Ron Shapiro,Matthew Cooper,George S. Lipkowitz,Michael A. Rees,Christopher L. Marsh,B. R. Sankari,David A. Gerber,P. W. Nelson,Jason R. Wellen,Adel Bozorgzadeh,A O Gaber,Robert A. Montgomery,Dorry L. Segev +31 more
TL;DR: Incompatible live donor kidney transplantation offers a survival advantage over dialysis to patients with anti‐HLA donor‐specific antibody (DSA) and program‐specific reports (PSRs) fail to account for ILDKT, placing this practice at regulatory risk.